The latest data, presented at VIVA

Clinical trial summaries presented at VIVA21 (in order of presentation):


Tuesday, October 5 – 9:15-10:10am

Click here to see the Tuesday morning press release with trial summaries

5-Year Outcomes from the IN.PACT Global Study Prespecified Cohorts: Chronic Total Occlusions, Long Lesions, and In-Stent Restenosis
Gunnar Tepe, MD


2-Year Results of the RANGER II SFA Randomized Trial: RANGER Drug-Coated Balloon vs Uncoated Balloons Overall and for Women, Patients with Occlusions, or Moderate/Severe Calcification
Ravish Sachar, MD

Racial Differences in Presentation and Outcomes After Peripheral Vascular Interventions: Insights from the NCDR-PVI Registry
Howard Julien, MD

Real-World Evaluation of Disparities in Critical Limb Ischemia Management Associated with Major Limb Amputation
Eric Secemsky, MD, MSc

Tuesday, October 5 – 1:15-2:10pm

Click here to see the Tuesday afternoon press release with trial summaries

KNOCOUT PE: Retrospective and Prospective International EKoSoNic® Registry of the Treatment and Clinical Outcomes of Patients with Pulmonary Embolism
Keith Sterling, MD

A Prospective Multicenter Trial of Pharmacomechanical Catheter-Directed Thrombolysis with the BASHIR™ Endovascular Catheter for Intermediate Risk Acute Pulmonary Embolism – Interim Analysis of The RESCUE Study
Akhilesh Sista, MD

5-Year VenaSeal Outcomes for Symptomatic Saphenous Incompetence: Is This the Clear Choice?
Morwan Bahi, MBChB

VIVO Clinical Study of the Zilver® Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction: 3-Year Outcomes
Paul Gagne, MD

Wednesday, October 6 – 9:15-10:10am

Click here to see the Wednesday morning press release with trial summaries

IN.PACT AV Access Study 24-month Outcomes by Lesion Characteristics
Robert Lookstein, MD, MHCDL

The EMINENT Study: Primary Results of the Randomized Trial of Eluvia DES vs Bare Metal Stents
Yann Gouëffic, MD, PhD

Utility of Sirolimus Drug-Eluting Balloons in the Treatment of Complex Below-the-Knee Atherosclerotic Disease in Patients with Chronic Limb-Threatening Ischemia–18-Month Results from the PRESTIGE Study
Tjun Tang, MD

Intravascular Lithotripsy for Peripheral Artery Calcification: Interim Analysis of 752 Patients from the Disrupt PAD III Observational Study
Ehrin Armstrong, MD


Wednesday, October 6 – 1:15-2:10pm

Click here to see the Wednesday afternoon press release with trial summaries

2-Year PROMISE I Results with the LimFlow Deep Vein Arterialization System
Daniel Clair, MD

MIMICS-3D: Claudicants and CLI Patients Treated with BioMimics 3D Have Similar Patency at 2 Years
Sahil A. Parikh, MD

INSIGHT: Evaluation of the Pantheris OCT-Imaging Atherectomy System in Treatment of In-Stent Restenosis (ISR) Occlusions in Lower Extremity Arteries
Jon George, MD

Amplifi Treatment Prior to AVF Creation
Surendra Shenoy, MD, PhD

Embargo Policy

VIVA embargoes Late-Breaking Clinical Trial information from becoming public until after the commencement of the session as listed in the conference program or on viva-foundation.org. No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented.

Submissions for VIVA22

The Late-Breaking Clinical Trial submission portal will reopen in Spring 2022. To be added to our mailing list and receive future updates, please email contact@vivaphysicians.org.